Global Study on Bone Marrow Transplant Market, 2015-2021

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
Persistence Market Research
<strong>Global</strong> Bone Marrow Transplant Market to
Reach 96,099 Units by 2021 and Europe
Market Revenue to Surge over US$ 6.02 Bn
by 2021: Persistence Market Research
Persistence Market Research 1

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
Persistence Market Research Released New Market Report According to a new market report
published by Persistence Market Research “<strong>Global</strong> Market <strong>Study</strong> on Bone Marrow
Transplant: Latin America to Register Highest Growth Rate by 2021, Owing to
Increasing Density of Bone Marrow Transplant Centers”.
Revenue from the global bone marrow transplant market is anticipated to expand at a CAGR
of 4.1% during the forecast period. By procedure type, the market is divided into segments
viz. autologous bone marrow transplant and allogeneic bone marrow transplant. Allogeneic
bone marrow transplant procedure segment accounted for a highest revenue share of 63.4%
in 2014, and revenue from this segment is expected to expand at CAGR of 4.4%, thereby
accounting for market share to 65.7%. However, in terms of volume, the autologous bone
marrow transplant procedure segment is expected to continue to lead the global bone
marrow transplant market as a result of increasing adoption of the procedure owing to low
chances of side effects. On the basis of disease indications, the leukemia segment is
expected to remain the leading segment and is expected to be valued at US$ 2,679.6 Mn by
the end of 2021. By disease indication, lymphoma segment currently ranks second in terms
of both value and volume.
By end user, the market is segmented into hospitals, multispecialty clinics, and ambulatory
surgical centers (ASC). Among these, hospital end user segment leads the global bone
marrow transplant market, accounting for over 91% volume share of global bone marrow
transplant market in 2014. This is partly attributed to requirement for advanced healthcare
infrastructure for conducting the procedure. The multispecialty clinics segment is expected
to register highest CAGR of 4.8% during the forecast period, with 1.4X increase in procedural
count.
Market growth is primarily driven by factors such as global increase in prevalence of blood
cancers, expansion of bone marrow transplant registry, growing investment in logistic
services, and improvement in survival rate after treatment. Being a procedure with the
likelihood of highest success rate for the treatment of leukemia and other blood cancers,
adoption of bone marrow transplant procedures is increasing, and is expected to fuel market
growth to a significant extent over the forecast period. However, high cost of the treatment,
scarcity of bone marrow donors, and uncertainty of reimbursement in several developing
Persistence Market Research 2

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
countries are factors expected to hamper growth of the global bone marrow transplant
market over the forecast period.
This report covers trends in the global market as well as trends for each segment, and offers
analysis of market potential. <strong>Global</strong>ly, the market in Europe is expected to remain dominant
among other markets in the global bone marrow transplant market, accounting for over 59%
revenue share. This is attributed to high density of bone marrow transplant centers in the
region and expanding bone marrow registries. The market in Latin America is anticipated to
witness rapid increase growth in terms of volume owing to high number of potential
candidates for the procedure.
The report begins with the evolution of the bone marrow transplant procedure, offering an
overview of the global bone marrow transplant market in terms of value and volume.
Comparative analysis of bone marrow transplant centers and number of procedures being
conducted annually in regions such as North America, Europe, Latin America, Asia-Pacific,
and Middle East & Africa explains the reasons for gaps in the market.
Request Sample Report: http://www.persistencemarketresearch.com/samples/4288
Key market players covered in this report include Lonza Group Ltd., Merck Millipore
Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type
Culture Collection (ATCC) Inc.
View Detail Report With TOC: http://www.persistencemarketresearch.com/marketresearch/bone-marrow-transplantation-market.asp
Market History:
Bone marrow transplant refers to the replacement of diseased or damaged bone marrow
with healthy tissue or bone marrow stem cells in order to treat blood cancer or various cases
of anemia. Depending on the source of bone marrow or stem cells, bone marrow transplant
procedures are classified as peripheral stem cell transplant (PSCT) or conventional bone
marrow transplant. Based on procedure type, the bone marrow transplant market has been
Persistence Market Research 3

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
segmented into autologous bone marrow transplant and allogeneic bone marrow transplant
segments. On the basis of disease indication, the market is classified into segments viz.
leukemia, lymphoma, myeloma, myelodysplasia, myeloproliferative neoplasms, aplastic
anemia, solid tumors, sickle cell anemia, thalassemia, and others. As per end user, bone
marrow transplant market is segmented into hospitals, multispecialty clinics, and
ambulatory surgical centers (ASC).
Revenue from the global bone marrow transplant market is projected to expand at a steady
CAGR of 3.9% over forecast period 2015–2021 and is expected to be valued at US$10.3 Bn
by the end of 2021. Among other markets globally, the market in Europe is expected to
remain dominant in terms of value and volume throughout the forecast period.
Major factors driving the growth of the global bone marrow transplant market include
increasing the prevalence of blood cancers and anemia, expanding bone marrow transplant
registries, growing investment in logistic services, and increasing survival rate after
treatment. Moreover, factors such as advances in technology, increasing per capita
healthcare expenditure, and improvement in healthcare infrastructure are also expected to
fuel the growth of the global bone marrow transplant market. However, shortage of bone
marrow donors, uncertainty about reimbursement, and the high cost of treatment are the
major factors expected to hamper the growth of the global bone marrow transplant market.
Owing to relatively less involvement of risks, autologous bone marrow transplant procedures
are being adopted at a faster rate. Hence by procedure type, autologous bone marrow
transplant segment accounted for the major proportion of the overall market volume in 2014
and is expected to remain the leading segment in terms of volume during the forecast
period. By disease indication, the leukemia segment is expected to dominate the market,
accounting for 26.5% share of the overall market revenue by 2021 end. Revenue
contribution from the thalassemia segment is projected to expand at the highest CAGR of
8.9% during the forecast period.
Based on regional segmentation, the market in Europe is expected to continue to lead the
global market due to increasing number of bone marrow transplant centers and expansion of
bone marrow registry. The MEA market is expected to witness sluggish growth during the
forecast period partly due to the relatively low presence of bone marrow transplant centers
Persistence Market Research 4

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
in the region. Latin America market revenue is expected to expand at healthy CAGR of 6.0%
due to increasing density of bone marrow transplant centers.
Top players in bone marrow transplantation market covered in this report are Lonza Group
Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies,
and American Type Culture Collection (ATCC) Inc. Companies need to launch innovative
products to leverage potential opportunities expected to be created by the global bone
marrow transplant market.
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated
research, custom research, and consulting services. PMR boasts market research expertise across the
Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages,
Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The
company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data
that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
305 Broadway
Persistence Market Research 5

<strong>Global</strong> <strong>Study</strong> on Bone Marrow Transplant Market, 2015-2021
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
Persistence Market Research 6